Company patents
Withings
Withings, surprisingly, shows a strong and sustained focus on core medical device innovation, with Medical Diagnostics & Surgery patents constituting 52.7% of its portfolio and experiencing significant growth of 71.4% in 2024 and 25.0% in 2025. While there's an emerging focus on Material & Chemical Analysis, growing by 66.7% in 2025, the sharp decline in Web & Cloud Service Protocols (YoY -100.0% in 2024) and Coating & Surface Treatment (YoY -100.0% so far in 2026) suggests a shifting priority away from these areas, despite the partial data for 2026.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
74 US filings (since 2023) · 5 categories · 4 themes
Methods and compositions for identifying, quantifying, or characterizing specific biological molecules (e.g., nucleic acids, proteins, metabolites, antibodies) or microbial species, often for diagnostic, prognostic, or quality control applications.
Development of devices and methods for non-invasive or minimally invasive collection and analysis of physiological data, often from wearable sensors, to monitor health, activity, or specific conditions.
Self-contained or modular devices designed to automate and integrate multiple steps of molecular diagnostic assays, from sample preparation to result interpretation, often for point-of-care or high-throughput applications.
Miniaturized devices that manipulate small volumes of fluids (nanoliters to picoliters) through microchannels to perform laboratory functions like mixing, separation, reaction, and detection on a single chip.
Patents
Showing 1-10 of 92